[1][2] Her dissertation was titled, Systemic autoimmune rheumatic diseases and breast cancer risk in elderly women.

[2] Gadalla's research interests focus on identifying and characterizing individuals at high risk of developing cancer and discovering predictive and prognostic biomarkers that may guide therapeutic decisions for those patients.

[2] In 2011, Gadalla and colleagues were the first to report epidemiological evidence of excess cancer risk in myotonic dystrophy (DM) patients.

[2] Gadalla's work focuses on severe aplastic anemia and myeloid neoplasms with a goal of identifying biomarkers that can guide donor selection or patient risk stratification.

[2] Her investigations include markers of cellular aging, germline genetic variants, and somatic copy-number alterations.